AzTrials
AzTrials

Developmental DyslexiaNCT05972200

V5/MT Stimulation on Reading and Reading-related Measures in Developmental Dyslexia

A study testing Active HD-tDCS over V5/MT and Active HD-tDCS over V1 in people with Developmental Dyslexia, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study grounds on the absence of evidence-based treatment in individuals with developmental dyslexia (DD). At this topic, the present study will explore the potential effect of transcranial direct current stimulation (tDCS) over left hemispheric direct Lateral Geniculate Nucleus (LGN)-V5/MT pathway… Read more about this study

Who is it for?
Ages 8 to 13 yearsHealthy volunteers can take part
Conditions the study is for
Developmental Dyslexia
What is being tested?
Active HD-tDCS over V5/MT and Active HD-tDCS over V1
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteItaly
Study dates
1 Sep 2023to 31 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 13 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Italian speakers right-handed children and adolescents with dyslexia (DSM-5, APA 2013);
  • Word/nonword/text reading accuracy and/or speed at least 2 Standard Deviations below the mean for school-age;
  • nv IQ ≥ 85;
  • normal hearing and normal or corrected-to-normal vision.

Who cannot join

  • Having a comorbidity with other primary psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD);
  • Having a personal history of neurological/medical/genetic diseases;
  • Having ongoing drug treatment influencing brain function;
  • Having epilepsy o family history of epilepsy.

Trial locations and contacts

1 site in 1 country.

Giulia Lazzaro contact

giulia.lazzaro@opbg.net

Italy1 site, 1 recruiting
  • Bambino Gesù Hospital and Research Institute

    Roma, 00165

    Deny Menghini, 06.6859.2875, deny.menghini@opbg.net

    Rita Alparone, 06.6859.2859, rita.alparone@opbg.net

    Recruiting

Other trials in Italy

About this study

Official title: Probing the Efficacy of V5/MT Stimulation on Reading and Reading-related Measures in Children and Adolescents With Developmental Dyslexia

The present study grounds on the absence of evidence-based treatment in individuals with developmental dyslexia (DD). At this topic, the present study will explore the potential effect of transcranial direct current stimulation (tDCS) over left hemispheric direct Lateral Geniculate Nucleus (LGN)-V5/MT pathway, cerebral areas usually disrupted in individuals with DD.

The investigators hypothesized that active tDCS over V5/MT will boost reading skills in children and adolescents with DD. On the contrary, sham (placebo condition) tDCS over V5/MT or active (control condition) tDCS over V1 will not have significant effect in improving reading skills. Further, both active and sham tDCS will be safe and well tolerated.

Read the detailed description

Over the last few decades, a huge number of studies has revealed that Developmental Dyslexia (DD), a brain-based neurodevelopmental disorder characterized by a severe and persistent impairment in the acquisition of reading skills may depend on multiple neurocognitive impairments, ranging from language-specific to cognitive-general deficits. Besides the most influential hypothesis of a phonological core deficit, there is also evidence for difficulties in low-level visual-temporal information processing, as the magnocellular deficit theory supports, as well as for visual-spatial attentional deficits, visual-perceptual impairments, and rapid automatized naming (RAN)-speed deficits.

Replicated structural/functional neuroimaging studies have demonstrated a DD hypoactivation relative to typical readers in the left temporo-occipital regions-critical for the automatic visual processing of word strings or print-and in the left temporo-parietal regions-important for grapheme-to-phoneme mapping.

Moreover, findings from animal models and post mortem studies in humans suggest that DD might also be associated with structural alterations in subcortical sensory pathways, particularly in visual and auditory thalamic nuclei and in their connections with high-order sensory cortices (i.e., the left hemispheric direct Lateral Geniculate Nucleus (LGN)-V5/MT pathway and the left hemispheric direct Medial Geniculate Body (MGB)-mPT pathway). In addition, in adults with DD, left V5/MT-LGN connectivity strength correlated with RAN abilities - a key deficit in DD.

A number of studies have demonstrated the positive effect of transcranial direct current stimulation (tDCS), a non-invasive brain stimulation used for transiently modifying neural activity of target areas, on reading and, particularly, in DD.

However, the few non-invasive brain stimulation studies on improving reading in DD yielded heterogeneous results and this variability might be partly due to the lack of neurobiological understanding of the underlying DD mechanism or to the use of traditional tDCS rather than a more focal technique such as the high-definition tDCS (HD-tDCS).

Starting from this, the aim of the current study is testing the effectiveness of a cutting-edge stimulation technique (i.e., HD-tDCS) in a within-subject experiment involving children and adolescents with DD. Especially, we will work to test i) the specific effect of HD-tDCS over high-order sensory cortices (i.e., V5/MT vs V1) on reading in children with DD; ii) the preconditions and neurobiological mechanisms that lead to high treatment outcomes.

If the stimulation over V5/MT is effective and specifically related to reading improvement, our results could help to i) understand the contribution and neurobiological mechanism of V5/MT in reading of children and adolescents with DD; ii) select criteria for potential responders to non-invasive brain stimulation; iii) develop evidence-based interventions in DD.

Being tested
Active HD-tDCS over V5/MT, Active HD-tDCS over V1, Sham HD-tDCS over V5/MT or V1
Keywords
Children, Adolescents, tDCS, transcranial direct current stimulation, neurodevelopmental disorders, non-invasive brain stimulation, transcranial electrical stimulation, EEG, reading abilities
Medical subject headings
Dyslexia, Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active HD-tDCS over V5/MTDevice

    For HD-tDCS a 4 × 1 montage (Kessler et al., 2013), small circular electrodes (diameter 1 cm) will be used with the anode placed centrally with a current intensity of 1 mA for a total of 20 minutes (30 s ramp up/down). Hereby, the anodal electrode modulates the excitability of the targeted area left V5/MT, whereas the other 4 electrodes return electrical currents that flow away from that area. V5/MT will be localised via published procedures and electrode's placement will be done according to the 10-20 International EEG 10-20 System for electrode placement.

  • Active HD-tDCS over V1Device

    For HD-tDCS a 4 × 1 montage (Kessler et al., 2013), small circular electrodes (diameter 1 cm) will be used with the anode placed centrally with a current intensity of 1 mA for a total of 20 minutes (30 s ramp up/down). Hereby, the anodal electrode modulates the excitability of the targeted area left V1, whereas the other 4 electrodes return electrical currents that flow away from that area. V1 will be localised via published procedures and electrode's placement will be done according to the 10-20 International EEG 10-20 System for electrode placement.

  • Sham HD-tDCS over V5/MT or V1Device

    Sham HD-tDCS will be delivered over left V5/MT or left V1. The same electrodes placement as well as the stimulation set-up will be used as in the active stimulation conditions, but the current will be applied for 30 s and will be ramped down (0 mA) during the rest of the session without the participants awareness. .

Study groups in NCT05972200
Study groupRoleWhat they receive
HD-tDCS V5/MT, HD-tDCS V1, ShamExperimental1. Active HD-tDCS over V5/MT 2. Active HD-tDCS over V1 3. Sham HD-tDCS over V5/MT or V1
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1
HD-tDCS V5/MT, Sham, HD-tDCS V1Experimental1. Active HD-tDCS over V5/MT 2. Sham HD-tDCS over V5/MT or V1 3. Active HD-tDCS over V1
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1
HD-tDCS V1, HD-tDCS V5/MT, ShamExperimental1. Active HD-tDCS over V1 2. Active HD-tDCS over V5/MT 3. Sham HD-tDCS over V5/MT or V1
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1
HD-tDCS V1, Sham, HD-tDCS V5/MTExperimental1. Active HD-tDCS over V1 2. Sham HD-tDCS over V5/MT or V1 3. Active HD-tDCS over V5/MT
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1
Sham, HD-tDCS V5/MT, HD-tDCS V1Experimental1. Sham HD-tDCS over V5/MT or V1 2. Active HD-tDCS over V5/MT 3. Active HD-tDCS over V1
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1
Sham, HD-tDCS V1, HD-tDCS V5/MTExperimental1. Sham HD-tDCS over V5/MT or V1 2. Active HD-tDCS over V1 3. Active HD-tDCS over V5/MT
Receives: Device: Active HD-tDCS over V5/MT; Device: Active HD-tDCS over V1; Device: Sham HD-tDCS over V5/MT or V1

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Text reading accuracy (Experimental reading task)

    Change in text reading accuracy from baseline compared after to Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Text reading accuracy is considered as the percentage (%) of accuracy and computed as the ratio between the number of correctly read stimuli and the total number of stimuli presented multiplied by 100.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  2. Text reading speed (Experimental reading task)

    Change in text reading speed from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Text reading speed is considered as the syllables/seconds ratio and calculated dividing the total number of syllables pronounced by the total time spent to complete the reading (in seconds).

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

Secondary outcomes (9)
  1. Word reading accuracy (Experimental reading task)

    Change in word reading accuracy from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Word reading accuracy is considered as the percentage (%) of accuracy and computed as the ratio between the number of correctly read stimuli and the total number of stimuli presented multiplied by 100.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  2. Word reading speed (Experimental reading task)

    Change in word reading speed from baseline compared to after Active HD-tDCS over V5/MT sessions than during Active HD-tDCS over V1 and Sham sessions. Word reading speed is considered as the syllables/seconds ratio and calculated dividing the total number of syllables pronounced by the total time spent to complete the reading (in seconds).

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  3. Non-word reading accuracy (Experimental reading task)

    Change in non-word reading accuracy from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Non-word reading accuracy is considered as the percentage (%) of accuracy and computed as the ratio between the number of correctly read stimuli and the total number of stimuli presented multiplied by 100.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  4. Non-word reading speed (Experimental reading task)

    Change in non-word reading speed from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Non-word reading speed is considered as the syllables/seconds ratio and calculated dividing the total number of syllables pronounced by the total time spent to complete the reading (in seconds).

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  5. Right visual hemisphere-motion perception (Experimental reading task)

    Change in right visual hemisphere-motion perception from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Right visual hemisphere-motion perception is considered as the number of correct saccades.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  6. Rapid automatized naming letter and number (Experimental reading task)

    Change in rapid automatized naming letter and number from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Rapid automatized naming letter and number is considered as the total time spent (in seconds) to complete the task.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  7. Phoneme blending (Experimental reading task)

    Change in phoneme blending from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Phoneme blending is considered as the number of correctly blended phonemes.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  8. Eye-movements during reading (Experimental reading task)

    Change in eye-movements from baseline compared to after reading during Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Eye-movements during reading is considered as the number of saccades and the number of dwells.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

  9. Spontaneous EEG (Experimental reading task)

    Change in spontaneous EEG from baseline compared to after Active HD-tDCS over V5/MT sessions than after Active HD-tDCS over V1 and Sham sessions. Spontaneous EEG is considered as the individual alpha-peak frequency and the beta and theta/gamma oscillations.

    The time points will be pre- (baseline) vs post-stimulation session.

    Measured: during procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2023
  2. Study start1 Sep 2023 (estimated)
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05972200
Sponsor's protocol ID
3073_OPBG_2023
Status last verified
Aug 2023
First submitted
25 Jul 2023
Last updated
4 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.): DSM 5. Washington, DC: American Psychiatric Association. 2013.

  • Snowling, M. Dyslexia, 2nd ed.; Blackwell Publishing: Oxford, UK. 2000.

  • Wolf M, Bowers PG. The double-deficit hypothesis for the developmental dyslexias. Journal of Educational Psychology. 1999; 91(3): 415-438.

  • Menghini D, Finzi A, Benassi M, Bolzani R, Facoetti A, Giovagnoli S, Ruffino M, Vicari S. Different underlying neurocognitive deficits in developmental dyslexia: a comparative study. Neuropsychologia. 2010 Mar;48(4):863-72. doi: 10.1016/j.neuropsychologia.2009.11.003. Epub 2009 Nov 10.

    PubMed 19909762
  • Vellutino FR, Fletcher JM, Snowling MJ, Scanlon DM. Specific reading disability (dyslexia): what have we learned in the past four decades? J Child Psychol Psychiatry. 2004 Jan;45(1):2-40. doi: 10.1046/j.0021-9630.2003.00305.x.

    PubMed 14959801
  • Melby-Lervag M, Lyster SA, Hulme C. Phonological skills and their role in learning to read: a meta-analytic review. Psychol Bull. 2012 Mar;138(2):322-52. doi: 10.1037/a0026744. Epub 2012 Jan 16.

    PubMed 22250824
  • Schulte-Korne G, Bruder J. Clinical neurophysiology of visual and auditory processing in dyslexia: a review. Clin Neurophysiol. 2010 Nov;121(11):1794-809. doi: 10.1016/j.clinph.2010.04.028. Epub 2010 May 31.

    PubMed 20570212
  • Vidyasagar TR, Pammer K. Dyslexia: a deficit in visuo-spatial attention, not in phonological processing. Trends Cogn Sci. 2010 Feb;14(2):57-63. doi: 10.1016/j.tics.2009.12.003. Epub 2010 Jan 14.

    PubMed 20080053
  • Franceschini S, Gori S, Ruffino M, Pedrolli K, Facoetti A. A causal link between visual spatial attention and reading acquisition. Curr Biol. 2012 May 8;22(9):814-9. doi: 10.1016/j.cub.2012.03.013. Epub 2012 Apr 5.

    PubMed 22483940
  • Bosse ML, Tainturier MJ, Valdois S. Developmental dyslexia: the visual attention span deficit hypothesis. Cognition. 2007 Aug;104(2):198-230. doi: 10.1016/j.cognition.2006.05.009. Epub 2006 Jul 21.

    PubMed 16859667
  • Stenneken P, Egetemeir J, Schulte-Korne G, Muller HJ, Schneider WX, Finke K. Slow perceptual processing at the core of developmental dyslexia: a parameter-based assessment of visual attention. Neuropsychologia. 2011 Oct;49(12):3454-65. doi: 10.1016/j.neuropsychologia.2011.08.021. Epub 2011 Aug 31.

    PubMed 21903119
  • Giovagnoli G, Vicari S, Tomassetti S, Menghini D. The Role of Visual-Spatial Abilities in Dyslexia: Age Differences in Children's Reading? Front Psychol. 2016 Dec 21;7:1997. doi: 10.3389/fpsyg.2016.01997. eCollection 2016.

    PubMed 28066311
  • Wang Z, Cheng-Lai A, Song Y, Cutting L, Jiang Y, Lin O, Meng X, Zhou X. A perceptual learning deficit in Chinese developmental dyslexia as revealed by visual texture discrimination training. Dyslexia. 2014 Aug;20(3):280-96. doi: 10.1002/dys.1475. Epub 2014 Mar 18.

    PubMed 24643918
  • Bowers PG, Wolf, M. Theoretical links among naming speed, precise timing mechanisms and orthographic skill in dyslexia. Reading and Writing.1993; 51: 69-85.

  • Richlan F, Kronbichler M, Wimmer H. Meta-analyzing brain dysfunctions in dyslexic children and adults. Neuroimage. 2011 Jun 1;56(3):1735-42. doi: 10.1016/j.neuroimage.2011.02.040. Epub 2011 Feb 19.

    PubMed 21338695

Questions about this trial

What is this clinical trial studying?

A study testing Active HD-tDCS over V5/MT and Active HD-tDCS over V1 in people with Developmental Dyslexia, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Deny Menghini (06.6859.2875, deny.menghini@opbg.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Text reading accuracy (Experimental reading task) (time frame: during procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05972200, which also lists 34 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in